DE1617397C3 - Herstellung eines tumorstatisch wirkenden Mittels durch Züchten von Streptococcus haemolyticus - Google Patents

Herstellung eines tumorstatisch wirkenden Mittels durch Züchten von Streptococcus haemolyticus

Info

Publication number
DE1617397C3
DE1617397C3 DE1617397A DEC0041691A DE1617397C3 DE 1617397 C3 DE1617397 C3 DE 1617397C3 DE 1617397 A DE1617397 A DE 1617397A DE C0041691 A DEC0041691 A DE C0041691A DE 1617397 C3 DE1617397 C3 DE 1617397C3
Authority
DE
Germany
Prior art keywords
minutes
suspension
cocci
penicillin
tumor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE1617397A
Other languages
German (de)
English (en)
Other versions
DE1617397A1 (de
DE1617397B2 (de
Inventor
Saburo Koshimura
Hajime Okamoto
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Chugai Pharmaceutical Co Ltd
KH Neochem Co Ltd
Original Assignee
Chugai Pharmaceutical Co Ltd
Kyowa Hakko Kogyo Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chugai Pharmaceutical Co Ltd, Kyowa Hakko Kogyo Co Ltd filed Critical Chugai Pharmaceutical Co Ltd
Publication of DE1617397A1 publication Critical patent/DE1617397A1/de
Publication of DE1617397B2 publication Critical patent/DE1617397B2/de
Application granted granted Critical
Publication of DE1617397C3 publication Critical patent/DE1617397C3/de
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P1/00—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
    • C12P1/04—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes by using bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/46—Streptococcus ; Enterococcus; Lactococcus
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/885—Streptococcus

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Microbiology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Mycology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Soil Working Implements (AREA)
DE1617397A 1966-03-08 1967-03-06 Herstellung eines tumorstatisch wirkenden Mittels durch Züchten von Streptococcus haemolyticus Expired DE1617397C3 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP1378466 1966-03-08

Publications (3)

Publication Number Publication Date
DE1617397A1 DE1617397A1 (de) 1971-03-18
DE1617397B2 DE1617397B2 (de) 1979-05-03
DE1617397C3 true DE1617397C3 (de) 1980-01-03

Family

ID=11842860

Family Applications (1)

Application Number Title Priority Date Filing Date
DE1617397A Expired DE1617397C3 (de) 1966-03-08 1967-03-06 Herstellung eines tumorstatisch wirkenden Mittels durch Züchten von Streptococcus haemolyticus

Country Status (15)

Country Link
US (1) US3477914A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
BE (1) BE695122A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CA (1) CA950847A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CH (1) CH526959A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CS (1) CS150186B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DE (1) DE1617397C3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DK (1) DK115652B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ES (1) ES337684A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
FR (1) FR6516M (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
GB (1) GB1132676A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NL (1) NL6703623A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NO (1) NO121972B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
SE (1) SE348943B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
SU (1) SU520055A3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
YU (1) YU33209B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3627644A (en) * 1968-03-01 1971-12-14 Hajime Okamoto Process for the cultivation of hemolytic streptococci
JPS496096B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) * 1970-09-30 1974-02-12
JPS54157815A (en) * 1978-05-29 1979-12-13 Chugai Pharmaceut Co Ltd Anti-tumor substance and its preparation
JPS557014A (en) * 1978-06-29 1980-01-18 Chugai Pharmaceut Co Ltd Antitumor agent and its preparation
JPS5679622A (en) * 1979-12-04 1981-06-30 Kanebo Ltd Antitumor pharmaceutical
GB2079785B (en) * 1980-04-14 1984-10-03 Kanebo Ltd Process for cultivation of hemolytic streptococcus pyogenes
FR2481314A1 (fr) * 1980-04-25 1981-10-30 Kanebo Ltd Procede de culture du micro-organisme streptococcus pyogenes hemolytique
US4401653A (en) * 1981-03-09 1983-08-30 Ayerst, Mckenna & Harrison Inc. Combination of rapamycin and picibanil for the treatment of tumors
WO1986004243A1 (en) * 1985-01-25 1986-07-31 The Population Council, Inc. Method & product for enhancing circulating antibody response
WO2024151554A2 (en) 2023-01-09 2024-07-18 Protara Therapeutics, Inc. Combination of non-viable cells of streptococcus pyogenes and immune checkpoint inhibitor for the treatment of triple negative breast cancer and non-muscle invasive bladder cancer

Also Published As

Publication number Publication date
DK115652B (da) 1969-10-27
CA950847A (en) 1974-07-09
CH526959A (de) 1972-08-31
DE1617397A1 (de) 1971-03-18
US3477914A (en) 1969-11-11
YU45267A (en) 1975-12-31
NL6703623A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1967-09-11
SE348943B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1972-09-18
GB1132676A (en) 1968-11-06
FR6516M (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1968-12-09
YU33209B (en) 1976-06-30
SU520055A3 (ru) 1976-06-30
BE695122A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1967-08-14
CS150186B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1973-09-04
DE1617397B2 (de) 1979-05-03
ES337684A1 (es) 1968-03-01
NO121972B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1971-05-03

Similar Documents

Publication Publication Date Title
DE3517629C2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DE4134854C2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DE1617397C3 (de) Herstellung eines tumorstatisch wirkenden Mittels durch Züchten von Streptococcus haemolyticus
DE2900591A1 (de) Antibiotica, ein verfahren zu ihrer herstellung sowie ihre verwendung als pflanzenschutzmittel
DE69810024T2 (de) Inhibitor der immunoglobulin e antikörpererzeugung zur behandlung von typ i allergie-verwandten krankheiten
DE2152112C3 (de) Impfstoff gegen Pseudomonas aeruginosa
DE2004686A1 (de) Antibiotica und Verfahren zu ihrer Herstellung
DE2209018C2 (de) Glycopeptid-Antibioticum-A-4696-Hydrochlorid und dieses enthaltendes Tierfuttermittel
DE1115888B (de) Verfahren zur Herstellung eines Streptokinase-Praeparates
DE3030107C2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DE2342404C3 (de) 3-(5,7-Dimethyl-2-hydroxy-4-oxo-6,8-decadienyI)-glutarimid sowie Verfahren zu dessen Herstellung
DE2921829C2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
EP0057812A2 (de) Neues Peptid-Antibiotikum Komponente A, Verfahren zu seiner Herstellung sowie seine Verwendung in Arzneimitteln
DE1717100C (de) Verfahren zur Herstellung von Prapara ten hamolytischer Streptococcen zur unter stutzenden Behandlung von Carcinomerkrankun gen
DE1617416C (de) Verfahren zur Herstellung hamolyti scher Streptococcen
DE1795154C3 (de) Verfahren zur Herstellung eines neuen, Tuberactin genannten antibiotischen Wirkstoffes
DE1695364C (de) Verfahren zur Herstellung von 2 Nitroimidazolen
DE1617951C3 (de) Verfahren zur Herstellung von Kasugamycin
DE1492002B1 (de) Das Antibiotikum Alanosin und Verfahren zu seiner Herstellung
DE2138588A1 (de) Antibiotikum CP 21 635 und Verfahren zu seiner Herstellung
DE2011618A1 (de) Enzyme zur Hydrolyse von Dextran
DES0040266MA (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DE1617416B (de) Verfahren zur Herstellung hämolytischer Streptococcen
DE1087763B (de) Herstellung und Gewinnung des Antibioticums 5278 R. P.
DE1717100B (de) Verfahren zur Herstellung von Präparaten hämolytischer Streptococcen zur unterstützenden Behandlung von Carcinomerkrankungen

Legal Events

Date Code Title Description
C3 Grant after two publication steps (3rd publication)